NEW YORK (Reuters Health) – Brentuximab vedotin can be safely combined with the second-line triple-agent chemotherapy regimen most commonly used in the U.S. for relapsed
Read more
Home ยป
NEW YORK (Reuters Health) – Brentuximab vedotin can be safely combined with the second-line triple-agent chemotherapy regimen most commonly used in the U.S. for relapsed
Read moreA lymph node collection kit can help surgeons attain compete resection and improve long-term survival after curative-intent lung cancer surgery, according to a study published
Read more